Related Experiment Video
Updated: Jul 13, 2026

A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
[Invasive Streptococcus agalactiae infections in non-pregnant adults]
N Lefebvre1, E Forestier, M Mohseni-Zadeh
1Service des maladies infectieuses et tropicales, centre hospitalier universitaire de Strasbourg, 1, place de l'Hôpital, 67091 Strasbourg cedex, France. n.lefebvre@yahoo.fr
Objectives:
Streptococcus agalactiae (Group B streptococcus) is a major cause of invasive diseases in non-pregnant adults, particularly in the elderly and those with underlying conditions. We describe these conditions and clinical characteristics of patients followed in our teaching hospital.
Methods:
We retrospectively reviewed clinical records of 64 patients with S. agalactiae-related invasive infection, hospitalized between January 1997 and January 2006.
Results:
The mean age of patients was 59 (+/-17 years). The H:F sex ratio was 1.06. At least one underlying condition was found in 90.6%. Diabetes mellitus (43.7%), peripheral vascular disease (34.4%), myocardial ischemia (20.3%) and malignant neoplasms (20.3%) were among the most frequent conditions. The mean index of comorbidity (Charlson) was 2.5 (+/-2). Common clinical manifestations included infection of the urinary tract (32.8%), skin and soft-tissue (25%), and osteoarthritis (21.9%). Bacteremia occurred in 31.2% with no identified source in 2 patients. During the first month, 2 cases of endocarditis, 1 case of meningitis, and 4 deaths occurred.
Conclusion:
We confirm the importance of underlying diseases in the emergence of S. agalactiae infections.
Related Concept Videos
Staphylococcal Skin Infections
Streptococcal Pharyngitis
Bacterial Meningitis I: Introduction
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies. Common...
Endocarditis III: Medical Management
Acute Pyelonephritis II: Diagnostic Studies and Management